Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose short-course methylprednisolone for early acute pancreatitis with systemic inflammatory response syndrome
ChiCTR-TRC-14004942Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Jul 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methylprednisolone in acute pancreatitis (AP) (2 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoints: Organ failure rate and duration, Rate and duration of abdominal compartment syndrome and 1 more. Planned start Jul 2014; status: not yet recruiting.
02
Drugs
methylprednisolone
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on ChiCTR-TRC-14004942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004942.